SPIA
DYN icon

Steward Partners Investment Advisory’s Dyne Therapeutics DYN Stock Holding History

Steward Partners Investment Advisory’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$125K Buy
6,880
+2,000
+41% +$34.5K ﹤0.01% 2257
2025
Q4 		$95.5K Buy
4,880
+2,465
+102% +$46.7K ﹤0.01% 2321
2025
Q3 		$30.6K Buy
2,415
+1,065
+79% +$12.1K ﹤0.01% 2884
2025
Q2 		$12.9K Buy
+1,350
New +$14.9K ﹤0.01% 3101
2025
Q1 		– Sell
-610
Closed -$14.4K – 4047
2024
Q4 		$14.4K Buy
610
+235
+63% +$6.95K ﹤0.01% 2942
2024
Q3 		$13.5K Buy
+375
New +$14.9K ﹤0.01% 2833

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Steward Partners Investment Advisory's DYN Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Dyne Therapeutics (DYN) stake by 41% in Q1 2026, buying an estimated $34.5K and bringing the position to 6,880 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #2257.

Steward Partners Investment Advisory first reported a position in DYN in Q3 2024 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Steward Partners Investment Advisory held 6,880 shares of Dyne Therapeutics worth $125K as of Q1 2026.
  • Steward Partners Investment Advisory bought 2,000 Dyne Therapeutics shares in Q1 2026, an estimated $34.5K.
  • Dyne Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #2257 holding.
  • Steward Partners Investment Advisory first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.